Lymerix, the first vaccine on the market to prevent Lyme disease

January 1999

People will be asking about Lymerix, the first vaccine on the market to prevent Lyme disease.

Lymerix is useful for people age 15 to 70 who spend a lot of time outdoors in areas where Lyme disease is common...primarily the Northeast, upper Midwest, and Pacific coastal areas.

The approved regimen is 3 doses at 0, 1, and 12 months. But giving the third dose SOONER...at 3 or 6 months also seems effective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote